Viewing Study NCT00052520


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-04-26 @ 12:39 AM
Study NCT ID: NCT00052520
Status: COMPLETED
Last Update Posted: 2017-03-29
First Post: 2003-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities View
None Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) View
None Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) View
None B-cell Adult Acute Lymphoblastic Leukemia View
None B-cell Childhood Acute Lymphoblastic Leukemia View
None Childhood Chronic Myelogenous Leukemia View
None Childhood Myelodysplastic Syndromes View
None Chronic Myelomonocytic Leukemia View
None Essential Thrombocythemia View
None Polycythemia Vera View
None Previously Treated Myelodysplastic Syndromes View
None Recurrent Adult Acute Lymphoblastic Leukemia View
None Recurrent Adult Acute Myeloid Leukemia View
None Recurrent Childhood Acute Lymphoblastic Leukemia View
None Recurrent Childhood Acute Myeloid Leukemia View
None Refractory Anemia With Excess Blasts View
None Refractory Anemia With Excess Blasts in Transformation View
None Relapsing Chronic Myelogenous Leukemia View
None Secondary Acute Myeloid Leukemia View
None T-cell Adult Acute Lymphoblastic Leukemia View
None T-cell Childhood Acute Lymphoblastic Leukemia View
Keywords: